Global Drugs for Osteoarthritis Pain Market Growth (Status and Outlook) 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Drugs for Osteoarthritis Pain market size is predicted to grow from US$ 10660 million in 2025 to US$ 15230 million in 2031; it is expected to grow at a CAGR of 6.1% from 2025 to 2031.
Drugs for Osteoarthritis Pain market, the main role of osteoarthritis pain drugs is to relieve pain, and cannot slow the progress of osteoarthritis.
North America is the largest Drugs for Osteoarthritis Pain market with about 36% market share. Europe is follower, accounting for about 27% market share.
The key players are Pfizer, Johnson & Johnson, GlaxoSmithKline, Bayer, Eli Lilly, Novartis, Sanofi, Horizon Pharma, Abbott, Mylan, Daiichi Sankyo, TEVA, Almatica Pharma, Astellas Pharma, Tide Pharmaceutical, Iroko Pharmaceuticals, Hengrui Pharmaceutical, Abiogen Pharma etc. Top 5 companies occupied about 66% market share.
LPI (LP Information)' newest research report, the “Drugs for Osteoarthritis Pain Industry Forecast” looks at past sales and reviews total world Drugs for Osteoarthritis Pain sales in 2024, providing a comprehensive analysis by region and market sector of projected Drugs for Osteoarthritis Pain sales for 2025 through 2031. With Drugs for Osteoarthritis Pain sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Drugs for Osteoarthritis Pain industry.
This Insight Report provides a comprehensive analysis of the global Drugs for Osteoarthritis Pain landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Drugs for Osteoarthritis Pain portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Drugs for Osteoarthritis Pain market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Drugs for Osteoarthritis Pain and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Drugs for Osteoarthritis Pain.
This report presents a comprehensive overview, market shares, and growth opportunities of Drugs for Osteoarthritis Pain market by product type, application, key players and key regions and countries.
Segmentation by Type:
The global Drugs for Osteoarthritis Pain market size is predicted to grow from US$ 10660 million in 2025 to US$ 15230 million in 2031; it is expected to grow at a CAGR of 6.1% from 2025 to 2031.
Drugs for Osteoarthritis Pain market, the main role of osteoarthritis pain drugs is to relieve pain, and cannot slow the progress of osteoarthritis.
North America is the largest Drugs for Osteoarthritis Pain market with about 36% market share. Europe is follower, accounting for about 27% market share.
The key players are Pfizer, Johnson & Johnson, GlaxoSmithKline, Bayer, Eli Lilly, Novartis, Sanofi, Horizon Pharma, Abbott, Mylan, Daiichi Sankyo, TEVA, Almatica Pharma, Astellas Pharma, Tide Pharmaceutical, Iroko Pharmaceuticals, Hengrui Pharmaceutical, Abiogen Pharma etc. Top 5 companies occupied about 66% market share.
LPI (LP Information)' newest research report, the “Drugs for Osteoarthritis Pain Industry Forecast” looks at past sales and reviews total world Drugs for Osteoarthritis Pain sales in 2024, providing a comprehensive analysis by region and market sector of projected Drugs for Osteoarthritis Pain sales for 2025 through 2031. With Drugs for Osteoarthritis Pain sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Drugs for Osteoarthritis Pain industry.
This Insight Report provides a comprehensive analysis of the global Drugs for Osteoarthritis Pain landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Drugs for Osteoarthritis Pain portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Drugs for Osteoarthritis Pain market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Drugs for Osteoarthritis Pain and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Drugs for Osteoarthritis Pain.
This report presents a comprehensive overview, market shares, and growth opportunities of Drugs for Osteoarthritis Pain market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Oral
- Injection
- External
- Medical Care
- Personal Care
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Pfizer
- Johnson & Johnson
- GlaxoSmithKline
- Bayer
- Eli Lilly
- Novartis
- Sanofi
- Horizon Pharma
- Abbott
- Mylan
- Daiichi Sankyo
- TEVA
- Almatica Pharma
- Astellas Pharma
- Tide Pharmaceutical
- Iroko Pharmaceuticals
- Hengrui Pharmaceutical
- Abiogen Pharma
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Drugs for Osteoarthritis Pain Market Size (2020-2031)
2.1.2 Drugs for Osteoarthritis Pain Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Drugs for Osteoarthritis Pain by Country/Region (2020, 2024 & 2031)
2.2 Drugs for Osteoarthritis Pain Segment by Type
2.2.1 Oral
2.2.2 Injection
2.2.3 External
2.3 Drugs for Osteoarthritis Pain Market Size by Type
2.3.1 Drugs for Osteoarthritis Pain Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Drugs for Osteoarthritis Pain Market Size Market Share by Type (2020-2025)
2.4 Drugs for Osteoarthritis Pain Segment by Application
2.4.1 Medical Care
2.4.2 Personal Care
2.5 Drugs for Osteoarthritis Pain Market Size by Application
2.5.1 Drugs for Osteoarthritis Pain Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Drugs for Osteoarthritis Pain Market Size Market Share by Application (2020-2025)
3 DRUGS FOR OSTEOARTHRITIS PAIN MARKET SIZE BY PLAYER
3.1 Drugs for Osteoarthritis Pain Market Size Market Share by Player
3.1.1 Global Drugs for Osteoarthritis Pain Revenue by Player (2020-2025)
3.1.2 Global Drugs for Osteoarthritis Pain Revenue Market Share by Player (2020-2025)
3.2 Global Drugs for Osteoarthritis Pain Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 DRUGS FOR OSTEOARTHRITIS PAIN BY REGION
4.1 Drugs for Osteoarthritis Pain Market Size by Region (2020-2025)
4.2 Global Drugs for Osteoarthritis Pain Annual Revenue by Country/Region (2020-2025)
4.3 Americas Drugs for Osteoarthritis Pain Market Size Growth (2020-2025)
4.4 APAC Drugs for Osteoarthritis Pain Market Size Growth (2020-2025)
4.5 Europe Drugs for Osteoarthritis Pain Market Size Growth (2020-2025)
4.6 Middle East & Africa Drugs for Osteoarthritis Pain Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Drugs for Osteoarthritis Pain Market Size by Country (2020-2025)
5.2 Americas Drugs for Osteoarthritis Pain Market Size by Type (2020-2025)
5.3 Americas Drugs for Osteoarthritis Pain Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Drugs for Osteoarthritis Pain Market Size by Region (2020-2025)
6.2 APAC Drugs for Osteoarthritis Pain Market Size by Type (2020-2025)
6.3 APAC Drugs for Osteoarthritis Pain Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Drugs for Osteoarthritis Pain Market Size by Country (2020-2025)
7.2 Europe Drugs for Osteoarthritis Pain Market Size by Type (2020-2025)
7.3 Europe Drugs for Osteoarthritis Pain Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Drugs for Osteoarthritis Pain by Region (2020-2025)
8.2 Middle East & Africa Drugs for Osteoarthritis Pain Market Size by Type (2020-2025)
8.3 Middle East & Africa Drugs for Osteoarthritis Pain Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL DRUGS FOR OSTEOARTHRITIS PAIN MARKET FORECAST
10.1 Global Drugs for Osteoarthritis Pain Forecast by Region (2026-2031)
10.1.1 Global Drugs for Osteoarthritis Pain Forecast by Region (2026-2031)
10.1.2 Americas Drugs for Osteoarthritis Pain Forecast
10.1.3 APAC Drugs for Osteoarthritis Pain Forecast
10.1.4 Europe Drugs for Osteoarthritis Pain Forecast
10.1.5 Middle East & Africa Drugs for Osteoarthritis Pain Forecast
10.2 Americas Drugs for Osteoarthritis Pain Forecast by Country (2026-2031)
10.2.1 United States Market Drugs for Osteoarthritis Pain Forecast
10.2.2 Canada Market Drugs for Osteoarthritis Pain Forecast
10.2.3 Mexico Market Drugs for Osteoarthritis Pain Forecast
10.2.4 Brazil Market Drugs for Osteoarthritis Pain Forecast
10.3 APAC Drugs for Osteoarthritis Pain Forecast by Region (2026-2031)
10.3.1 China Drugs for Osteoarthritis Pain Market Forecast
10.3.2 Japan Market Drugs for Osteoarthritis Pain Forecast
10.3.3 Korea Market Drugs for Osteoarthritis Pain Forecast
10.3.4 Southeast Asia Market Drugs for Osteoarthritis Pain Forecast
10.3.5 India Market Drugs for Osteoarthritis Pain Forecast
10.3.6 Australia Market Drugs for Osteoarthritis Pain Forecast
10.4 Europe Drugs for Osteoarthritis Pain Forecast by Country (2026-2031)
10.4.1 Germany Market Drugs for Osteoarthritis Pain Forecast
10.4.2 France Market Drugs for Osteoarthritis Pain Forecast
10.4.3 UK Market Drugs for Osteoarthritis Pain Forecast
10.4.4 Italy Market Drugs for Osteoarthritis Pain Forecast
10.4.5 Russia Market Drugs for Osteoarthritis Pain Forecast
10.5 Middle East & Africa Drugs for Osteoarthritis Pain Forecast by Region (2026-2031)
10.5.1 Egypt Market Drugs for Osteoarthritis Pain Forecast
10.5.2 South Africa Market Drugs for Osteoarthritis Pain Forecast
10.5.3 Israel Market Drugs for Osteoarthritis Pain Forecast
10.5.4 Turkey Market Drugs for Osteoarthritis Pain Forecast
10.6 Global Drugs for Osteoarthritis Pain Forecast by Type (2026-2031)
10.7 Global Drugs for Osteoarthritis Pain Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Drugs for Osteoarthritis Pain Forecast
11 KEY PLAYERS ANALYSIS
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Drugs for Osteoarthritis Pain Product Offered
11.1.3 Pfizer Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Pfizer Main Business Overview
11.1.5 Pfizer Latest Developments
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Information
11.2.2 Johnson & Johnson Drugs for Osteoarthritis Pain Product Offered
11.2.3 Johnson & Johnson Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Johnson & Johnson Main Business Overview
11.2.5 Johnson & Johnson Latest Developments
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Information
11.3.2 GlaxoSmithKline Drugs for Osteoarthritis Pain Product Offered
11.3.3 GlaxoSmithKline Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 GlaxoSmithKline Main Business Overview
11.3.5 GlaxoSmithKline Latest Developments
11.4 Bayer
11.4.1 Bayer Company Information
11.4.2 Bayer Drugs for Osteoarthritis Pain Product Offered
11.4.3 Bayer Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Bayer Main Business Overview
11.4.5 Bayer Latest Developments
11.5 Eli Lilly
11.5.1 Eli Lilly Company Information
11.5.2 Eli Lilly Drugs for Osteoarthritis Pain Product Offered
11.5.3 Eli Lilly Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Eli Lilly Main Business Overview
11.5.5 Eli Lilly Latest Developments
11.6 Novartis
11.6.1 Novartis Company Information
11.6.2 Novartis Drugs for Osteoarthritis Pain Product Offered
11.6.3 Novartis Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Novartis Main Business Overview
11.6.5 Novartis Latest Developments
11.7 Sanofi
11.7.1 Sanofi Company Information
11.7.2 Sanofi Drugs for Osteoarthritis Pain Product Offered
11.7.3 Sanofi Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Sanofi Main Business Overview
11.7.5 Sanofi Latest Developments
11.8 Horizon Pharma
11.8.1 Horizon Pharma Company Information
11.8.2 Horizon Pharma Drugs for Osteoarthritis Pain Product Offered
11.8.3 Horizon Pharma Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Horizon Pharma Main Business Overview
11.8.5 Horizon Pharma Latest Developments
11.9 Abbott
11.9.1 Abbott Company Information
11.9.2 Abbott Drugs for Osteoarthritis Pain Product Offered
11.9.3 Abbott Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Abbott Main Business Overview
11.9.5 Abbott Latest Developments
11.10 Mylan
11.10.1 Mylan Company Information
11.10.2 Mylan Drugs for Osteoarthritis Pain Product Offered
11.10.3 Mylan Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Mylan Main Business Overview
11.10.5 Mylan Latest Developments
11.11 Daiichi Sankyo
11.11.1 Daiichi Sankyo Company Information
11.11.2 Daiichi Sankyo Drugs for Osteoarthritis Pain Product Offered
11.11.3 Daiichi Sankyo Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Daiichi Sankyo Main Business Overview
11.11.5 Daiichi Sankyo Latest Developments
11.12 TEVA
11.12.1 TEVA Company Information
11.12.2 TEVA Drugs for Osteoarthritis Pain Product Offered
11.12.3 TEVA Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 TEVA Main Business Overview
11.12.5 TEVA Latest Developments
11.13 Almatica Pharma
11.13.1 Almatica Pharma Company Information
11.13.2 Almatica Pharma Drugs for Osteoarthritis Pain Product Offered
11.13.3 Almatica Pharma Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Almatica Pharma Main Business Overview
11.13.5 Almatica Pharma Latest Developments
11.14 Astellas Pharma
11.14.1 Astellas Pharma Company Information
11.14.2 Astellas Pharma Drugs for Osteoarthritis Pain Product Offered
11.14.3 Astellas Pharma Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Astellas Pharma Main Business Overview
11.14.5 Astellas Pharma Latest Developments
11.15 Tide Pharmaceutical
11.15.1 Tide Pharmaceutical Company Information
11.15.2 Tide Pharmaceutical Drugs for Osteoarthritis Pain Product Offered
11.15.3 Tide Pharmaceutical Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Tide Pharmaceutical Main Business Overview
11.15.5 Tide Pharmaceutical Latest Developments
11.16 Iroko Pharmaceuticals
11.16.1 Iroko Pharmaceuticals Company Information
11.16.2 Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Product Offered
11.16.3 Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 Iroko Pharmaceuticals Main Business Overview
11.16.5 Iroko Pharmaceuticals Latest Developments
11.17 Hengrui Pharmaceutical
11.17.1 Hengrui Pharmaceutical Company Information
11.17.2 Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Product Offered
11.17.3 Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2020-2025)
11.17.4 Hengrui Pharmaceutical Main Business Overview
11.17.5 Hengrui Pharmaceutical Latest Developments
11.18 Abiogen Pharma
11.18.1 Abiogen Pharma Company Information
11.18.2 Abiogen Pharma Drugs for Osteoarthritis Pain Product Offered
11.18.3 Abiogen Pharma Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2020-2025)
11.18.4 Abiogen Pharma Main Business Overview
11.18.5 Abiogen Pharma Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Drugs for Osteoarthritis Pain Market Size (2020-2031)
2.1.2 Drugs for Osteoarthritis Pain Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Drugs for Osteoarthritis Pain by Country/Region (2020, 2024 & 2031)
2.2 Drugs for Osteoarthritis Pain Segment by Type
2.2.1 Oral
2.2.2 Injection
2.2.3 External
2.3 Drugs for Osteoarthritis Pain Market Size by Type
2.3.1 Drugs for Osteoarthritis Pain Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Drugs for Osteoarthritis Pain Market Size Market Share by Type (2020-2025)
2.4 Drugs for Osteoarthritis Pain Segment by Application
2.4.1 Medical Care
2.4.2 Personal Care
2.5 Drugs for Osteoarthritis Pain Market Size by Application
2.5.1 Drugs for Osteoarthritis Pain Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Drugs for Osteoarthritis Pain Market Size Market Share by Application (2020-2025)
3 DRUGS FOR OSTEOARTHRITIS PAIN MARKET SIZE BY PLAYER
3.1 Drugs for Osteoarthritis Pain Market Size Market Share by Player
3.1.1 Global Drugs for Osteoarthritis Pain Revenue by Player (2020-2025)
3.1.2 Global Drugs for Osteoarthritis Pain Revenue Market Share by Player (2020-2025)
3.2 Global Drugs for Osteoarthritis Pain Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 DRUGS FOR OSTEOARTHRITIS PAIN BY REGION
4.1 Drugs for Osteoarthritis Pain Market Size by Region (2020-2025)
4.2 Global Drugs for Osteoarthritis Pain Annual Revenue by Country/Region (2020-2025)
4.3 Americas Drugs for Osteoarthritis Pain Market Size Growth (2020-2025)
4.4 APAC Drugs for Osteoarthritis Pain Market Size Growth (2020-2025)
4.5 Europe Drugs for Osteoarthritis Pain Market Size Growth (2020-2025)
4.6 Middle East & Africa Drugs for Osteoarthritis Pain Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Drugs for Osteoarthritis Pain Market Size by Country (2020-2025)
5.2 Americas Drugs for Osteoarthritis Pain Market Size by Type (2020-2025)
5.3 Americas Drugs for Osteoarthritis Pain Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Drugs for Osteoarthritis Pain Market Size by Region (2020-2025)
6.2 APAC Drugs for Osteoarthritis Pain Market Size by Type (2020-2025)
6.3 APAC Drugs for Osteoarthritis Pain Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Drugs for Osteoarthritis Pain Market Size by Country (2020-2025)
7.2 Europe Drugs for Osteoarthritis Pain Market Size by Type (2020-2025)
7.3 Europe Drugs for Osteoarthritis Pain Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Drugs for Osteoarthritis Pain by Region (2020-2025)
8.2 Middle East & Africa Drugs for Osteoarthritis Pain Market Size by Type (2020-2025)
8.3 Middle East & Africa Drugs for Osteoarthritis Pain Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL DRUGS FOR OSTEOARTHRITIS PAIN MARKET FORECAST
10.1 Global Drugs for Osteoarthritis Pain Forecast by Region (2026-2031)
10.1.1 Global Drugs for Osteoarthritis Pain Forecast by Region (2026-2031)
10.1.2 Americas Drugs for Osteoarthritis Pain Forecast
10.1.3 APAC Drugs for Osteoarthritis Pain Forecast
10.1.4 Europe Drugs for Osteoarthritis Pain Forecast
10.1.5 Middle East & Africa Drugs for Osteoarthritis Pain Forecast
10.2 Americas Drugs for Osteoarthritis Pain Forecast by Country (2026-2031)
10.2.1 United States Market Drugs for Osteoarthritis Pain Forecast
10.2.2 Canada Market Drugs for Osteoarthritis Pain Forecast
10.2.3 Mexico Market Drugs for Osteoarthritis Pain Forecast
10.2.4 Brazil Market Drugs for Osteoarthritis Pain Forecast
10.3 APAC Drugs for Osteoarthritis Pain Forecast by Region (2026-2031)
10.3.1 China Drugs for Osteoarthritis Pain Market Forecast
10.3.2 Japan Market Drugs for Osteoarthritis Pain Forecast
10.3.3 Korea Market Drugs for Osteoarthritis Pain Forecast
10.3.4 Southeast Asia Market Drugs for Osteoarthritis Pain Forecast
10.3.5 India Market Drugs for Osteoarthritis Pain Forecast
10.3.6 Australia Market Drugs for Osteoarthritis Pain Forecast
10.4 Europe Drugs for Osteoarthritis Pain Forecast by Country (2026-2031)
10.4.1 Germany Market Drugs for Osteoarthritis Pain Forecast
10.4.2 France Market Drugs for Osteoarthritis Pain Forecast
10.4.3 UK Market Drugs for Osteoarthritis Pain Forecast
10.4.4 Italy Market Drugs for Osteoarthritis Pain Forecast
10.4.5 Russia Market Drugs for Osteoarthritis Pain Forecast
10.5 Middle East & Africa Drugs for Osteoarthritis Pain Forecast by Region (2026-2031)
10.5.1 Egypt Market Drugs for Osteoarthritis Pain Forecast
10.5.2 South Africa Market Drugs for Osteoarthritis Pain Forecast
10.5.3 Israel Market Drugs for Osteoarthritis Pain Forecast
10.5.4 Turkey Market Drugs for Osteoarthritis Pain Forecast
10.6 Global Drugs for Osteoarthritis Pain Forecast by Type (2026-2031)
10.7 Global Drugs for Osteoarthritis Pain Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Drugs for Osteoarthritis Pain Forecast
11 KEY PLAYERS ANALYSIS
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Drugs for Osteoarthritis Pain Product Offered
11.1.3 Pfizer Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Pfizer Main Business Overview
11.1.5 Pfizer Latest Developments
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Information
11.2.2 Johnson & Johnson Drugs for Osteoarthritis Pain Product Offered
11.2.3 Johnson & Johnson Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Johnson & Johnson Main Business Overview
11.2.5 Johnson & Johnson Latest Developments
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Information
11.3.2 GlaxoSmithKline Drugs for Osteoarthritis Pain Product Offered
11.3.3 GlaxoSmithKline Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 GlaxoSmithKline Main Business Overview
11.3.5 GlaxoSmithKline Latest Developments
11.4 Bayer
11.4.1 Bayer Company Information
11.4.2 Bayer Drugs for Osteoarthritis Pain Product Offered
11.4.3 Bayer Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Bayer Main Business Overview
11.4.5 Bayer Latest Developments
11.5 Eli Lilly
11.5.1 Eli Lilly Company Information
11.5.2 Eli Lilly Drugs for Osteoarthritis Pain Product Offered
11.5.3 Eli Lilly Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Eli Lilly Main Business Overview
11.5.5 Eli Lilly Latest Developments
11.6 Novartis
11.6.1 Novartis Company Information
11.6.2 Novartis Drugs for Osteoarthritis Pain Product Offered
11.6.3 Novartis Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Novartis Main Business Overview
11.6.5 Novartis Latest Developments
11.7 Sanofi
11.7.1 Sanofi Company Information
11.7.2 Sanofi Drugs for Osteoarthritis Pain Product Offered
11.7.3 Sanofi Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Sanofi Main Business Overview
11.7.5 Sanofi Latest Developments
11.8 Horizon Pharma
11.8.1 Horizon Pharma Company Information
11.8.2 Horizon Pharma Drugs for Osteoarthritis Pain Product Offered
11.8.3 Horizon Pharma Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Horizon Pharma Main Business Overview
11.8.5 Horizon Pharma Latest Developments
11.9 Abbott
11.9.1 Abbott Company Information
11.9.2 Abbott Drugs for Osteoarthritis Pain Product Offered
11.9.3 Abbott Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Abbott Main Business Overview
11.9.5 Abbott Latest Developments
11.10 Mylan
11.10.1 Mylan Company Information
11.10.2 Mylan Drugs for Osteoarthritis Pain Product Offered
11.10.3 Mylan Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Mylan Main Business Overview
11.10.5 Mylan Latest Developments
11.11 Daiichi Sankyo
11.11.1 Daiichi Sankyo Company Information
11.11.2 Daiichi Sankyo Drugs for Osteoarthritis Pain Product Offered
11.11.3 Daiichi Sankyo Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Daiichi Sankyo Main Business Overview
11.11.5 Daiichi Sankyo Latest Developments
11.12 TEVA
11.12.1 TEVA Company Information
11.12.2 TEVA Drugs for Osteoarthritis Pain Product Offered
11.12.3 TEVA Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 TEVA Main Business Overview
11.12.5 TEVA Latest Developments
11.13 Almatica Pharma
11.13.1 Almatica Pharma Company Information
11.13.2 Almatica Pharma Drugs for Osteoarthritis Pain Product Offered
11.13.3 Almatica Pharma Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Almatica Pharma Main Business Overview
11.13.5 Almatica Pharma Latest Developments
11.14 Astellas Pharma
11.14.1 Astellas Pharma Company Information
11.14.2 Astellas Pharma Drugs for Osteoarthritis Pain Product Offered
11.14.3 Astellas Pharma Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Astellas Pharma Main Business Overview
11.14.5 Astellas Pharma Latest Developments
11.15 Tide Pharmaceutical
11.15.1 Tide Pharmaceutical Company Information
11.15.2 Tide Pharmaceutical Drugs for Osteoarthritis Pain Product Offered
11.15.3 Tide Pharmaceutical Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Tide Pharmaceutical Main Business Overview
11.15.5 Tide Pharmaceutical Latest Developments
11.16 Iroko Pharmaceuticals
11.16.1 Iroko Pharmaceuticals Company Information
11.16.2 Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Product Offered
11.16.3 Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 Iroko Pharmaceuticals Main Business Overview
11.16.5 Iroko Pharmaceuticals Latest Developments
11.17 Hengrui Pharmaceutical
11.17.1 Hengrui Pharmaceutical Company Information
11.17.2 Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Product Offered
11.17.3 Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2020-2025)
11.17.4 Hengrui Pharmaceutical Main Business Overview
11.17.5 Hengrui Pharmaceutical Latest Developments
11.18 Abiogen Pharma
11.18.1 Abiogen Pharma Company Information
11.18.2 Abiogen Pharma Drugs for Osteoarthritis Pain Product Offered
11.18.3 Abiogen Pharma Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2020-2025)
11.18.4 Abiogen Pharma Main Business Overview
11.18.5 Abiogen Pharma Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Drugs for Osteoarthritis Pain Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Drugs for Osteoarthritis Pain Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Oral
Table 4. Major Players of Injection
Table 5. Major Players of External
Table 6. Drugs for Osteoarthritis Pain Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 7. Global Drugs for Osteoarthritis Pain Market Size by Type (2020-2025) & ($ millions)
Table 8. Global Drugs for Osteoarthritis Pain Market Size Market Share by Type (2020-2025)
Table 9. Drugs for Osteoarthritis Pain Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global Drugs for Osteoarthritis Pain Market Size by Application (2020-2025) & ($ millions)
Table 11. Global Drugs for Osteoarthritis Pain Market Size Market Share by Application (2020-2025)
Table 12. Global Drugs for Osteoarthritis Pain Revenue by Player (2020-2025) & ($ millions)
Table 13. Global Drugs for Osteoarthritis Pain Revenue Market Share by Player (2020-2025)
Table 14. Drugs for Osteoarthritis Pain Key Players Head office and Products Offered
Table 15. Drugs for Osteoarthritis Pain Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Drugs for Osteoarthritis Pain Market Size by Region (2020-2025) & ($ millions)
Table 19. Global Drugs for Osteoarthritis Pain Market Size Market Share by Region (2020-2025)
Table 20. Global Drugs for Osteoarthritis Pain Revenue by Country/Region (2020-2025) & ($ millions)
Table 21. Global Drugs for Osteoarthritis Pain Revenue Market Share by Country/Region (2020-2025)
Table 22. Americas Drugs for Osteoarthritis Pain Market Size by Country (2020-2025) & ($ millions)
Table 23. Americas Drugs for Osteoarthritis Pain Market Size Market Share by Country (2020-2025)
Table 24. Americas Drugs for Osteoarthritis Pain Market Size by Type (2020-2025) & ($ millions)
Table 25. Americas Drugs for Osteoarthritis Pain Market Size Market Share by Type (2020-2025)
Table 26. Americas Drugs for Osteoarthritis Pain Market Size by Application (2020-2025) & ($ millions)
Table 27. Americas Drugs for Osteoarthritis Pain Market Size Market Share by Application (2020-2025)
Table 28. APAC Drugs for Osteoarthritis Pain Market Size by Region (2020-2025) & ($ millions)
Table 29. APAC Drugs for Osteoarthritis Pain Market Size Market Share by Region (2020-2025)
Table 30. APAC Drugs for Osteoarthritis Pain Market Size by Type (2020-2025) & ($ millions)
Table 31. APAC Drugs for Osteoarthritis Pain Market Size by Application (2020-2025) & ($ millions)
Table 32. Europe Drugs for Osteoarthritis Pain Market Size by Country (2020-2025) & ($ millions)
Table 33. Europe Drugs for Osteoarthritis Pain Market Size Market Share by Country (2020-2025)
Table 34. Europe Drugs for Osteoarthritis Pain Market Size by Type (2020-2025) & ($ millions)
Table 35. Europe Drugs for Osteoarthritis Pain Market Size by Application (2020-2025) & ($ millions)
Table 36. Middle East & Africa Drugs for Osteoarthritis Pain Market Size by Region (2020-2025) & ($ millions)
Table 37. Middle East & Africa Drugs for Osteoarthritis Pain Market Size by Type (2020-2025) & ($ millions)
Table 38. Middle East & Africa Drugs for Osteoarthritis Pain Market Size by Application (2020-2025) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Drugs for Osteoarthritis Pain
Table 40. Key Market Challenges & Risks of Drugs for Osteoarthritis Pain
Table 41. Key Industry Trends of Drugs for Osteoarthritis Pain
Table 42. Global Drugs for Osteoarthritis Pain Market Size Forecast by Region (2026-2031) & ($ millions)
Table 43. Global Drugs for Osteoarthritis Pain Market Size Market Share Forecast by Region (2026-2031)
Table 44. Global Drugs for Osteoarthritis Pain Market Size Forecast by Type (2026-2031) & ($ millions)
Table 45. Global Drugs for Osteoarthritis Pain Market Size Forecast by Application (2026-2031) & ($ millions)
Table 46. Pfizer Details, Company Type, Drugs for Osteoarthritis Pain Area Served and Its Competitors
Table 47. Pfizer Drugs for Osteoarthritis Pain Product Offered
Table 48. Pfizer Drugs for Osteoarthritis Pain Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 49. Pfizer Main Business
Table 50. Pfizer Latest Developments
Table 51. Johnson & Johnson Details, Company Type, Drugs for Osteoarthritis Pain Area Served and Its Competitors
Table 52. Johnson & Johnson Drugs for Osteoarthritis Pain Product Offered
Table 53. Johnson & Johnson Drugs for Osteoarthritis Pain Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 54. Johnson & Johnson Main Business
Table 55. Johnson & Johnson Latest Developments
Table 56. GlaxoSmithKline Details, Company Type, Drugs for Osteoarthritis Pain Area Served and Its Competitors
Table 57. GlaxoSmithKline Drugs for Osteoarthritis Pain Product Offered
Table 58. GlaxoSmithKline Drugs for Osteoarthritis Pain Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 59. GlaxoSmithKline Main Business
Table 60. GlaxoSmithKline Latest Developments
Table 61. Bayer Details, Company Type, Drugs for Osteoarthritis Pain Area Served and Its Competitors
Table 62. Bayer Drugs for Osteoarthritis Pain Product Offered
Table 63. Bayer Drugs for Osteoarthritis Pain Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 64. Bayer Main Business
Table 65. Bayer Latest Developments
Table 66. Eli Lilly Details, Company Type, Drugs for Osteoarthritis Pain Area Served and Its Competitors
Table 67. Eli Lilly Drugs for Osteoarthritis Pain Product Offered
Table 68. Eli Lilly Drugs for Osteoarthritis Pain Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 69. Eli Lilly Main Business
Table 70. Eli Lilly Latest Developments
Table 71. Novartis Details, Company Type, Drugs for Osteoarthritis Pain Area Served and Its Competitors
Table 72. Novartis Drugs for Osteoarthritis Pain Product Offered
Table 73. Novartis Drugs for Osteoarthritis Pain Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 74. Novartis Main Business
Table 75. Novartis Latest Developments
Table 76. Sanofi Details, Company Type, Drugs for Osteoarthritis Pain Area Served and Its Competitors
Table 77. Sanofi Drugs for Osteoarthritis Pain Product Offered
Table 78. Sanofi Drugs for Osteoarthritis Pain Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 79. Sanofi Main Business
Table 80. Sanofi Latest Developments
Table 81. Horizon Pharma Details, Company Type, Drugs for Osteoarthritis Pain Area Served and Its Competitors
Table 82. Horizon Pharma Drugs for Osteoarthritis Pain Product Offered
Table 83. Horizon Pharma Drugs for Osteoarthritis Pain Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 84. Horizon Pharma Main Business
Table 85. Horizon Pharma Latest Developments
Table 86. Abbott Details, Company Type, Drugs for Osteoarthritis Pain Area Served and Its Competitors
Table 87. Abbott Drugs for Osteoarthritis Pain Product Offered
Table 88. Abbott Drugs for Osteoarthritis Pain Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 89. Abbott Main Business
Table 90. Abbott Latest Developments
Table 91. Mylan Details, Company Type, Drugs for Osteoarthritis Pain Area Served and Its Competitors
Table 92. Mylan Drugs for Osteoarthritis Pain Product Offered
Table 93. Mylan Drugs for Osteoarthritis Pain Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 94. Mylan Main Business
Table 95. Mylan Latest Developments
Table 96. Daiichi Sankyo Details, Company Type, Drugs for Osteoarthritis Pain Area Served and Its Competitors
Table 97. Daiichi Sankyo Drugs for Osteoarthritis Pain Product Offered
Table 98. Daiichi Sankyo Drugs for Osteoarthritis Pain Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 99. Daiichi Sankyo Main Business
Table 100. Daiichi Sankyo Latest Developments
Table 101. TEVA Details, Company Type, Drugs for Osteoarthritis Pain Area Served and Its Competitors
Table 102. TEVA Drugs for Osteoarthritis Pain Product Offered
Table 103. TEVA Drugs for Osteoarthritis Pain Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 104. TEVA Main Business
Table 105. TEVA Latest Developments
Table 106. Almatica Pharma Details, Company Type, Drugs for Osteoarthritis Pain Area Served and Its Competitors
Table 107. Almatica Pharma Drugs for Osteoarthritis Pain Product Offered
Table 108. Almatica Pharma Drugs for Osteoarthritis Pain Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 109. Almatica Pharma Main Business
Table 110. Almatica Pharma Latest Developments
Table 111. Astellas Pharma Details, Company Type, Drugs for Osteoarthritis Pain Area Served and Its Competitors
Table 112. Astellas Pharma Drugs for Osteoarthritis Pain Product Offered
Table 113. Astellas Pharma Drugs for Osteoarthritis Pain Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 114. Astellas Pharma Main Business
Table 115. Astellas Pharma Latest Developments
Table 116. Tide Pharmaceutical Details, Company Type, Drugs for Osteoarthritis Pain Area Served and Its Competitors
Table 117. Tide Pharmaceutical Drugs for Osteoarthritis Pain Product Offered
Table 118. Tide Pharmaceutical Drugs for Osteoarthritis Pain Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 119. Tide Pharmaceutical Main Business
Table 120. Tide Pharmaceutical Latest Developments
Table 121. Iroko Pharmaceuticals Details, Company Type, Drugs for Osteoarthritis Pain Area Served and Its Competitors
Table 122. Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Product Offered
Table 123. Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 124. Iroko Pharmaceuticals Main Business
Table 125. Iroko Pharmaceuticals Latest Developments
Table 126. Hengrui Pharmaceutical Details, Company Type, Drugs for Osteoarthritis Pain Area Served and Its Competitors
Table 127. Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Product Offered
Table 128. Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 129. Hengrui Pharmaceutical Main Business
Table 130. Hengrui Pharmaceutical Latest Developments
Table 131. Abiogen Pharma Details, Company Type, Drugs for Osteoarthritis Pain Area Served and Its Competitors
Table 132. Abiogen Pharma Drugs for Osteoarthritis Pain Product Offered
Table 133. Abiogen Pharma Drugs for Osteoarthritis Pain Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 134. Abiogen Pharma Main Business
Table 135. Abiogen Pharma Latest Developments
Table 1. Drugs for Osteoarthritis Pain Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Drugs for Osteoarthritis Pain Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Oral
Table 4. Major Players of Injection
Table 5. Major Players of External
Table 6. Drugs for Osteoarthritis Pain Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 7. Global Drugs for Osteoarthritis Pain Market Size by Type (2020-2025) & ($ millions)
Table 8. Global Drugs for Osteoarthritis Pain Market Size Market Share by Type (2020-2025)
Table 9. Drugs for Osteoarthritis Pain Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global Drugs for Osteoarthritis Pain Market Size by Application (2020-2025) & ($ millions)
Table 11. Global Drugs for Osteoarthritis Pain Market Size Market Share by Application (2020-2025)
Table 12. Global Drugs for Osteoarthritis Pain Revenue by Player (2020-2025) & ($ millions)
Table 13. Global Drugs for Osteoarthritis Pain Revenue Market Share by Player (2020-2025)
Table 14. Drugs for Osteoarthritis Pain Key Players Head office and Products Offered
Table 15. Drugs for Osteoarthritis Pain Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Drugs for Osteoarthritis Pain Market Size by Region (2020-2025) & ($ millions)
Table 19. Global Drugs for Osteoarthritis Pain Market Size Market Share by Region (2020-2025)
Table 20. Global Drugs for Osteoarthritis Pain Revenue by Country/Region (2020-2025) & ($ millions)
Table 21. Global Drugs for Osteoarthritis Pain Revenue Market Share by Country/Region (2020-2025)
Table 22. Americas Drugs for Osteoarthritis Pain Market Size by Country (2020-2025) & ($ millions)
Table 23. Americas Drugs for Osteoarthritis Pain Market Size Market Share by Country (2020-2025)
Table 24. Americas Drugs for Osteoarthritis Pain Market Size by Type (2020-2025) & ($ millions)
Table 25. Americas Drugs for Osteoarthritis Pain Market Size Market Share by Type (2020-2025)
Table 26. Americas Drugs for Osteoarthritis Pain Market Size by Application (2020-2025) & ($ millions)
Table 27. Americas Drugs for Osteoarthritis Pain Market Size Market Share by Application (2020-2025)
Table 28. APAC Drugs for Osteoarthritis Pain Market Size by Region (2020-2025) & ($ millions)
Table 29. APAC Drugs for Osteoarthritis Pain Market Size Market Share by Region (2020-2025)
Table 30. APAC Drugs for Osteoarthritis Pain Market Size by Type (2020-2025) & ($ millions)
Table 31. APAC Drugs for Osteoarthritis Pain Market Size by Application (2020-2025) & ($ millions)
Table 32. Europe Drugs for Osteoarthritis Pain Market Size by Country (2020-2025) & ($ millions)
Table 33. Europe Drugs for Osteoarthritis Pain Market Size Market Share by Country (2020-2025)
Table 34. Europe Drugs for Osteoarthritis Pain Market Size by Type (2020-2025) & ($ millions)
Table 35. Europe Drugs for Osteoarthritis Pain Market Size by Application (2020-2025) & ($ millions)
Table 36. Middle East & Africa Drugs for Osteoarthritis Pain Market Size by Region (2020-2025) & ($ millions)
Table 37. Middle East & Africa Drugs for Osteoarthritis Pain Market Size by Type (2020-2025) & ($ millions)
Table 38. Middle East & Africa Drugs for Osteoarthritis Pain Market Size by Application (2020-2025) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Drugs for Osteoarthritis Pain
Table 40. Key Market Challenges & Risks of Drugs for Osteoarthritis Pain
Table 41. Key Industry Trends of Drugs for Osteoarthritis Pain
Table 42. Global Drugs for Osteoarthritis Pain Market Size Forecast by Region (2026-2031) & ($ millions)
Table 43. Global Drugs for Osteoarthritis Pain Market Size Market Share Forecast by Region (2026-2031)
Table 44. Global Drugs for Osteoarthritis Pain Market Size Forecast by Type (2026-2031) & ($ millions)
Table 45. Global Drugs for Osteoarthritis Pain Market Size Forecast by Application (2026-2031) & ($ millions)
Table 46. Pfizer Details, Company Type, Drugs for Osteoarthritis Pain Area Served and Its Competitors
Table 47. Pfizer Drugs for Osteoarthritis Pain Product Offered
Table 48. Pfizer Drugs for Osteoarthritis Pain Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 49. Pfizer Main Business
Table 50. Pfizer Latest Developments
Table 51. Johnson & Johnson Details, Company Type, Drugs for Osteoarthritis Pain Area Served and Its Competitors
Table 52. Johnson & Johnson Drugs for Osteoarthritis Pain Product Offered
Table 53. Johnson & Johnson Drugs for Osteoarthritis Pain Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 54. Johnson & Johnson Main Business
Table 55. Johnson & Johnson Latest Developments
Table 56. GlaxoSmithKline Details, Company Type, Drugs for Osteoarthritis Pain Area Served and Its Competitors
Table 57. GlaxoSmithKline Drugs for Osteoarthritis Pain Product Offered
Table 58. GlaxoSmithKline Drugs for Osteoarthritis Pain Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 59. GlaxoSmithKline Main Business
Table 60. GlaxoSmithKline Latest Developments
Table 61. Bayer Details, Company Type, Drugs for Osteoarthritis Pain Area Served and Its Competitors
Table 62. Bayer Drugs for Osteoarthritis Pain Product Offered
Table 63. Bayer Drugs for Osteoarthritis Pain Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 64. Bayer Main Business
Table 65. Bayer Latest Developments
Table 66. Eli Lilly Details, Company Type, Drugs for Osteoarthritis Pain Area Served and Its Competitors
Table 67. Eli Lilly Drugs for Osteoarthritis Pain Product Offered
Table 68. Eli Lilly Drugs for Osteoarthritis Pain Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 69. Eli Lilly Main Business
Table 70. Eli Lilly Latest Developments
Table 71. Novartis Details, Company Type, Drugs for Osteoarthritis Pain Area Served and Its Competitors
Table 72. Novartis Drugs for Osteoarthritis Pain Product Offered
Table 73. Novartis Drugs for Osteoarthritis Pain Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 74. Novartis Main Business
Table 75. Novartis Latest Developments
Table 76. Sanofi Details, Company Type, Drugs for Osteoarthritis Pain Area Served and Its Competitors
Table 77. Sanofi Drugs for Osteoarthritis Pain Product Offered
Table 78. Sanofi Drugs for Osteoarthritis Pain Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 79. Sanofi Main Business
Table 80. Sanofi Latest Developments
Table 81. Horizon Pharma Details, Company Type, Drugs for Osteoarthritis Pain Area Served and Its Competitors
Table 82. Horizon Pharma Drugs for Osteoarthritis Pain Product Offered
Table 83. Horizon Pharma Drugs for Osteoarthritis Pain Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 84. Horizon Pharma Main Business
Table 85. Horizon Pharma Latest Developments
Table 86. Abbott Details, Company Type, Drugs for Osteoarthritis Pain Area Served and Its Competitors
Table 87. Abbott Drugs for Osteoarthritis Pain Product Offered
Table 88. Abbott Drugs for Osteoarthritis Pain Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 89. Abbott Main Business
Table 90. Abbott Latest Developments
Table 91. Mylan Details, Company Type, Drugs for Osteoarthritis Pain Area Served and Its Competitors
Table 92. Mylan Drugs for Osteoarthritis Pain Product Offered
Table 93. Mylan Drugs for Osteoarthritis Pain Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 94. Mylan Main Business
Table 95. Mylan Latest Developments
Table 96. Daiichi Sankyo Details, Company Type, Drugs for Osteoarthritis Pain Area Served and Its Competitors
Table 97. Daiichi Sankyo Drugs for Osteoarthritis Pain Product Offered
Table 98. Daiichi Sankyo Drugs for Osteoarthritis Pain Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 99. Daiichi Sankyo Main Business
Table 100. Daiichi Sankyo Latest Developments
Table 101. TEVA Details, Company Type, Drugs for Osteoarthritis Pain Area Served and Its Competitors
Table 102. TEVA Drugs for Osteoarthritis Pain Product Offered
Table 103. TEVA Drugs for Osteoarthritis Pain Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 104. TEVA Main Business
Table 105. TEVA Latest Developments
Table 106. Almatica Pharma Details, Company Type, Drugs for Osteoarthritis Pain Area Served and Its Competitors
Table 107. Almatica Pharma Drugs for Osteoarthritis Pain Product Offered
Table 108. Almatica Pharma Drugs for Osteoarthritis Pain Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 109. Almatica Pharma Main Business
Table 110. Almatica Pharma Latest Developments
Table 111. Astellas Pharma Details, Company Type, Drugs for Osteoarthritis Pain Area Served and Its Competitors
Table 112. Astellas Pharma Drugs for Osteoarthritis Pain Product Offered
Table 113. Astellas Pharma Drugs for Osteoarthritis Pain Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 114. Astellas Pharma Main Business
Table 115. Astellas Pharma Latest Developments
Table 116. Tide Pharmaceutical Details, Company Type, Drugs for Osteoarthritis Pain Area Served and Its Competitors
Table 117. Tide Pharmaceutical Drugs for Osteoarthritis Pain Product Offered
Table 118. Tide Pharmaceutical Drugs for Osteoarthritis Pain Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 119. Tide Pharmaceutical Main Business
Table 120. Tide Pharmaceutical Latest Developments
Table 121. Iroko Pharmaceuticals Details, Company Type, Drugs for Osteoarthritis Pain Area Served and Its Competitors
Table 122. Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Product Offered
Table 123. Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 124. Iroko Pharmaceuticals Main Business
Table 125. Iroko Pharmaceuticals Latest Developments
Table 126. Hengrui Pharmaceutical Details, Company Type, Drugs for Osteoarthritis Pain Area Served and Its Competitors
Table 127. Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Product Offered
Table 128. Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 129. Hengrui Pharmaceutical Main Business
Table 130. Hengrui Pharmaceutical Latest Developments
Table 131. Abiogen Pharma Details, Company Type, Drugs for Osteoarthritis Pain Area Served and Its Competitors
Table 132. Abiogen Pharma Drugs for Osteoarthritis Pain Product Offered
Table 133. Abiogen Pharma Drugs for Osteoarthritis Pain Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 134. Abiogen Pharma Main Business
Table 135. Abiogen Pharma Latest Developments
LIST OF FIGURES
Figure 1. Drugs for Osteoarthritis Pain Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Drugs for Osteoarthritis Pain Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Drugs for Osteoarthritis Pain Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Drugs for Osteoarthritis Pain Sales Market Share by Country/Region (2024)
Figure 8. Drugs for Osteoarthritis Pain Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Drugs for Osteoarthritis Pain Market Size Market Share by Type in 2024
Figure 10. Drugs for Osteoarthritis Pain in Medical Care
Figure 11. Global Drugs for Osteoarthritis Pain Market: Medical Care (2020-2025) & ($ millions)
Figure 12. Drugs for Osteoarthritis Pain in Personal Care
Figure 13. Global Drugs for Osteoarthritis Pain Market: Personal Care (2020-2025) & ($ millions)
Figure 14. Global Drugs for Osteoarthritis Pain Market Size Market Share by Application in 2024
Figure 15. Global Drugs for Osteoarthritis Pain Revenue Market Share by Player in 2024
Figure 16. Global Drugs for Osteoarthritis Pain Market Size Market Share by Region (2020-2025)
Figure 17. Americas Drugs for Osteoarthritis Pain Market Size 2020-2025 ($ millions)
Figure 18. APAC Drugs for Osteoarthritis Pain Market Size 2020-2025 ($ millions)
Figure 19. Europe Drugs for Osteoarthritis Pain Market Size 2020-2025 ($ millions)
Figure 20. Middle East & Africa Drugs for Osteoarthritis Pain Market Size 2020-2025 ($ millions)
Figure 21. Americas Drugs for Osteoarthritis Pain Value Market Share by Country in 2024
Figure 22. United States Drugs for Osteoarthritis Pain Market Size Growth 2020-2025 ($ millions)
Figure 23. Canada Drugs for Osteoarthritis Pain Market Size Growth 2020-2025 ($ millions)
Figure 24. Mexico Drugs for Osteoarthritis Pain Market Size Growth 2020-2025 ($ millions)
Figure 25. Brazil Drugs for Osteoarthritis Pain Market Size Growth 2020-2025 ($ millions)
Figure 26. APAC Drugs for Osteoarthritis Pain Market Size Market Share by Region in 2024
Figure 27. APAC Drugs for Osteoarthritis Pain Market Size Market Share by Type (2020-2025)
Figure 28. APAC Drugs for Osteoarthritis Pain Market Size Market Share by Application (2020-2025)
Figure 29. China Drugs for Osteoarthritis Pain Market Size Growth 2020-2025 ($ millions)
Figure 30. Japan Drugs for Osteoarthritis Pain Market Size Growth 2020-2025 ($ millions)
Figure 31. South Korea Drugs for Osteoarthritis Pain Market Size Growth 2020-2025 ($ millions)
Figure 32. Southeast Asia Drugs for Osteoarthritis Pain Market Size Growth 2020-2025 ($ millions)
Figure 33. India Drugs for Osteoarthritis Pain Market Size Growth 2020-2025 ($ millions)
Figure 34. Australia Drugs for Osteoarthritis Pain Market Size Growth 2020-2025 ($ millions)
Figure 35. Europe Drugs for Osteoarthritis Pain Market Size Market Share by Country in 2024
Figure 36. Europe Drugs for Osteoarthritis Pain Market Size Market Share by Type (2020-2025)
Figure 37. Europe Drugs for Osteoarthritis Pain Market Size Market Share by Application (2020-2025)
Figure 38. Germany Drugs for Osteoarthritis Pain Market Size Growth 2020-2025 ($ millions)
Figure 39. France Drugs for Osteoarthritis Pain Market Size Growth 2020-2025 ($ millions)
Figure 40. UK Drugs for Osteoarthritis Pain Market Size Growth 2020-2025 ($ millions)
Figure 41. Italy Drugs for Osteoarthritis Pain Market Size Growth 2020-2025 ($ millions)
Figure 42. Russia Drugs for Osteoarthritis Pain Market Size Growth 2020-2025 ($ millions)
Figure 43. Middle East & Africa Drugs for Osteoarthritis Pain Market Size Market Share by Region (2020-2025)
Figure 44. Middle East & Africa Drugs for Osteoarthritis Pain Market Size Market Share by Type (2020-2025)
Figure 45. Middle East & Africa Drugs for Osteoarthritis Pain Market Size Market Share by Application (2020-2025)
Figure 46. Egypt Drugs for Osteoarthritis Pain Market Size Growth 2020-2025 ($ millions)
Figure 47. South Africa Drugs for Osteoarthritis Pain Market Size Growth 2020-2025 ($ millions)
Figure 48. Israel Drugs for Osteoarthritis Pain Market Size Growth 2020-2025 ($ millions)
Figure 49. Turkey Drugs for Osteoarthritis Pain Market Size Growth 2020-2025 ($ millions)
Figure 50. GCC Countries Drugs for Osteoarthritis Pain Market Size Growth 2020-2025 ($ millions)
Figure 51. Americas Drugs for Osteoarthritis Pain Market Size 2026-2031 ($ millions)
Figure 52. APAC Drugs for Osteoarthritis Pain Market Size 2026-2031 ($ millions)
Figure 53. Europe Drugs for Osteoarthritis Pain Market Size 2026-2031 ($ millions)
Figure 54. Middle East & Africa Drugs for Osteoarthritis Pain Market Size 2026-2031 ($ millions)
Figure 55. United States Drugs for Osteoarthritis Pain Market Size 2026-2031 ($ millions)
Figure 56. Canada Drugs for Osteoarthritis Pain Market Size 2026-2031 ($ millions)
Figure 57. Mexico Drugs for Osteoarthritis Pain Market Size 2026-2031 ($ millions)
Figure 58. Brazil Drugs for Osteoarthritis Pain Market Size 2026-2031 ($ millions)
Figure 59. China Drugs for Osteoarthritis Pain Market Size 2026-2031 ($ millions)
Figure 60. Japan Drugs for Osteoarthritis Pain Market Size 2026-2031 ($ millions)
Figure 61. Korea Drugs for Osteoarthritis Pain Market Size 2026-2031 ($ millions)
Figure 62. Southeast Asia Drugs for Osteoarthritis Pain Market Size 2026-2031 ($ millions)
Figure 63. India Drugs for Osteoarthritis Pain Market Size 2026-2031 ($ millions)
Figure 64. Australia Drugs for Osteoarthritis Pain Market Size 2026-2031 ($ millions)
Figure 65. Germany Drugs for Osteoarthritis Pain Market Size 2026-2031 ($ millions)
Figure 66. France Drugs for Osteoarthritis Pain Market Size 2026-2031 ($ millions)
Figure 67. UK Drugs for Osteoarthritis Pain Market Size 2026-2031 ($ millions)
Figure 68. Italy Drugs for Osteoarthritis Pain Market Size 2026-2031 ($ millions)
Figure 69. Russia Drugs for Osteoarthritis Pain Market Size 2026-2031 ($ millions)
Figure 70. Egypt Drugs for Osteoarthritis Pain Market Size 2026-2031 ($ millions)
Figure 71. South Africa Drugs for Osteoarthritis Pain Market Size 2026-2031 ($ millions)
Figure 72. Israel Drugs for Osteoarthritis Pain Market Size 2026-2031 ($ millions)
Figure 73. Turkey Drugs for Osteoarthritis Pain Market Size 2026-2031 ($ millions)
Figure 74. Global Drugs for Osteoarthritis Pain Market Size Market Share Forecast by Type (2026-2031)
Figure 75. Global Drugs for Osteoarthritis Pain Market Size Market Share Forecast by Application (2026-2031)
Figure 76. GCC Countries Drugs for Osteoarthritis Pain Market Size 2026-2031 ($ millions)
Figure 1. Drugs for Osteoarthritis Pain Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Drugs for Osteoarthritis Pain Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Drugs for Osteoarthritis Pain Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Drugs for Osteoarthritis Pain Sales Market Share by Country/Region (2024)
Figure 8. Drugs for Osteoarthritis Pain Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Drugs for Osteoarthritis Pain Market Size Market Share by Type in 2024
Figure 10. Drugs for Osteoarthritis Pain in Medical Care
Figure 11. Global Drugs for Osteoarthritis Pain Market: Medical Care (2020-2025) & ($ millions)
Figure 12. Drugs for Osteoarthritis Pain in Personal Care
Figure 13. Global Drugs for Osteoarthritis Pain Market: Personal Care (2020-2025) & ($ millions)
Figure 14. Global Drugs for Osteoarthritis Pain Market Size Market Share by Application in 2024
Figure 15. Global Drugs for Osteoarthritis Pain Revenue Market Share by Player in 2024
Figure 16. Global Drugs for Osteoarthritis Pain Market Size Market Share by Region (2020-2025)
Figure 17. Americas Drugs for Osteoarthritis Pain Market Size 2020-2025 ($ millions)
Figure 18. APAC Drugs for Osteoarthritis Pain Market Size 2020-2025 ($ millions)
Figure 19. Europe Drugs for Osteoarthritis Pain Market Size 2020-2025 ($ millions)
Figure 20. Middle East & Africa Drugs for Osteoarthritis Pain Market Size 2020-2025 ($ millions)
Figure 21. Americas Drugs for Osteoarthritis Pain Value Market Share by Country in 2024
Figure 22. United States Drugs for Osteoarthritis Pain Market Size Growth 2020-2025 ($ millions)
Figure 23. Canada Drugs for Osteoarthritis Pain Market Size Growth 2020-2025 ($ millions)
Figure 24. Mexico Drugs for Osteoarthritis Pain Market Size Growth 2020-2025 ($ millions)
Figure 25. Brazil Drugs for Osteoarthritis Pain Market Size Growth 2020-2025 ($ millions)
Figure 26. APAC Drugs for Osteoarthritis Pain Market Size Market Share by Region in 2024
Figure 27. APAC Drugs for Osteoarthritis Pain Market Size Market Share by Type (2020-2025)
Figure 28. APAC Drugs for Osteoarthritis Pain Market Size Market Share by Application (2020-2025)
Figure 29. China Drugs for Osteoarthritis Pain Market Size Growth 2020-2025 ($ millions)
Figure 30. Japan Drugs for Osteoarthritis Pain Market Size Growth 2020-2025 ($ millions)
Figure 31. South Korea Drugs for Osteoarthritis Pain Market Size Growth 2020-2025 ($ millions)
Figure 32. Southeast Asia Drugs for Osteoarthritis Pain Market Size Growth 2020-2025 ($ millions)
Figure 33. India Drugs for Osteoarthritis Pain Market Size Growth 2020-2025 ($ millions)
Figure 34. Australia Drugs for Osteoarthritis Pain Market Size Growth 2020-2025 ($ millions)
Figure 35. Europe Drugs for Osteoarthritis Pain Market Size Market Share by Country in 2024
Figure 36. Europe Drugs for Osteoarthritis Pain Market Size Market Share by Type (2020-2025)
Figure 37. Europe Drugs for Osteoarthritis Pain Market Size Market Share by Application (2020-2025)
Figure 38. Germany Drugs for Osteoarthritis Pain Market Size Growth 2020-2025 ($ millions)
Figure 39. France Drugs for Osteoarthritis Pain Market Size Growth 2020-2025 ($ millions)
Figure 40. UK Drugs for Osteoarthritis Pain Market Size Growth 2020-2025 ($ millions)
Figure 41. Italy Drugs for Osteoarthritis Pain Market Size Growth 2020-2025 ($ millions)
Figure 42. Russia Drugs for Osteoarthritis Pain Market Size Growth 2020-2025 ($ millions)
Figure 43. Middle East & Africa Drugs for Osteoarthritis Pain Market Size Market Share by Region (2020-2025)
Figure 44. Middle East & Africa Drugs for Osteoarthritis Pain Market Size Market Share by Type (2020-2025)
Figure 45. Middle East & Africa Drugs for Osteoarthritis Pain Market Size Market Share by Application (2020-2025)
Figure 46. Egypt Drugs for Osteoarthritis Pain Market Size Growth 2020-2025 ($ millions)
Figure 47. South Africa Drugs for Osteoarthritis Pain Market Size Growth 2020-2025 ($ millions)
Figure 48. Israel Drugs for Osteoarthritis Pain Market Size Growth 2020-2025 ($ millions)
Figure 49. Turkey Drugs for Osteoarthritis Pain Market Size Growth 2020-2025 ($ millions)
Figure 50. GCC Countries Drugs for Osteoarthritis Pain Market Size Growth 2020-2025 ($ millions)
Figure 51. Americas Drugs for Osteoarthritis Pain Market Size 2026-2031 ($ millions)
Figure 52. APAC Drugs for Osteoarthritis Pain Market Size 2026-2031 ($ millions)
Figure 53. Europe Drugs for Osteoarthritis Pain Market Size 2026-2031 ($ millions)
Figure 54. Middle East & Africa Drugs for Osteoarthritis Pain Market Size 2026-2031 ($ millions)
Figure 55. United States Drugs for Osteoarthritis Pain Market Size 2026-2031 ($ millions)
Figure 56. Canada Drugs for Osteoarthritis Pain Market Size 2026-2031 ($ millions)
Figure 57. Mexico Drugs for Osteoarthritis Pain Market Size 2026-2031 ($ millions)
Figure 58. Brazil Drugs for Osteoarthritis Pain Market Size 2026-2031 ($ millions)
Figure 59. China Drugs for Osteoarthritis Pain Market Size 2026-2031 ($ millions)
Figure 60. Japan Drugs for Osteoarthritis Pain Market Size 2026-2031 ($ millions)
Figure 61. Korea Drugs for Osteoarthritis Pain Market Size 2026-2031 ($ millions)
Figure 62. Southeast Asia Drugs for Osteoarthritis Pain Market Size 2026-2031 ($ millions)
Figure 63. India Drugs for Osteoarthritis Pain Market Size 2026-2031 ($ millions)
Figure 64. Australia Drugs for Osteoarthritis Pain Market Size 2026-2031 ($ millions)
Figure 65. Germany Drugs for Osteoarthritis Pain Market Size 2026-2031 ($ millions)
Figure 66. France Drugs for Osteoarthritis Pain Market Size 2026-2031 ($ millions)
Figure 67. UK Drugs for Osteoarthritis Pain Market Size 2026-2031 ($ millions)
Figure 68. Italy Drugs for Osteoarthritis Pain Market Size 2026-2031 ($ millions)
Figure 69. Russia Drugs for Osteoarthritis Pain Market Size 2026-2031 ($ millions)
Figure 70. Egypt Drugs for Osteoarthritis Pain Market Size 2026-2031 ($ millions)
Figure 71. South Africa Drugs for Osteoarthritis Pain Market Size 2026-2031 ($ millions)
Figure 72. Israel Drugs for Osteoarthritis Pain Market Size 2026-2031 ($ millions)
Figure 73. Turkey Drugs for Osteoarthritis Pain Market Size 2026-2031 ($ millions)
Figure 74. Global Drugs for Osteoarthritis Pain Market Size Market Share Forecast by Type (2026-2031)
Figure 75. Global Drugs for Osteoarthritis Pain Market Size Market Share Forecast by Application (2026-2031)
Figure 76. GCC Countries Drugs for Osteoarthritis Pain Market Size 2026-2031 ($ millions)
More Publications
Global Drug Discovery Market Growth (Status and Outlook) 2024-2030
US$ 3,660.00
March 2024
110 pages
